Teaching Plan for Mr D: Diabetes and Metformin Management

This teaching plan focuses on a 69-year-old patient, Mr. D, a retired firefighter with type 2 diabetes and visual impairment. The plan aims to educate Mr. D on managing his condition through Metformin medication, diet, and exercise. It covers the drug's mechanism of action, dosage, side effects, and contraindications, emphasizing patient safety and the importance of adhering to medical advice. The plan also addresses the patient's visual impairment, suggesting teaching strategies using audio and visual aids for the carer. The teaching session will include information about the appropriate diet and physical exercises that should be combined with Metformin. The evaluation will involve questioning Mr. D and his carer at the end of the learning sessions. References are also provided to support the information.

Running Head: TEACHING PLAN 1
Mr D Teaching Plan
Name of Student
Name of Professor
Institution Affiliation
Date

TEACHING PLAN 2
Medication Teaching Plan Template
Health Teaching Plan
Framework
Health education is an important strategy for promotion of good
health practices and prevention of diseases. It provides learning
experiences on various health topics. This teaching plan is tailored to
meet the needs of 69-year-old patient who is a firefighter. Teaching
Mr D about the use of Metaformin in combination with diet to help
manage his diabetes. Since Mr D has lost his visual ability due to
diabetes type two, metaformin in combination with a proper diet and
physical exercises will play a critical role in helping the patient
manage the disease effectively (Stevens et al., 2018).
Overview of teaching
plan (synopsis of who,
what, when, where,
why, how will be
taught)
The teaching plan is aimed towards assisting Mr D to manage his
diabetes condition and overcome the visual impairment which is
caused by diabetes type two. The teaching plan will involve teaching
patient D how to use metaformin 500mg. The drugs should not be
used for patients with kidney diseases and the patient should inform
the doctor if the patient has an history of liver and heart diseases
(Kandula et al., 2018). Mr D will be advised on how to use the drug
and the type of meals and exercises that he should undertake while
taking the medication. The teaching will commence after one week
and it will be take three days. The teaching will happen at the clinic
which will provide access to all the facilities required to teach Mr D
regarding his condition and the medication that he should use. This is

TEACHING PLAN 3
because the medication has some side effects that the patient should
understand how to control. The metaformin should also be taken with
a special diet so that it can work properly and in order to minimize the
chances of having very low blood pressure. The teaching will also
involve family members who can assist Mr D with roles that they are
not able to perform due to vision impairment. The teaching will be
done through a lecture which will involve demonstration and
presentations and use of videos.
Two (2) Learning
Outcomes of teaching
session:
 Patient should understand the dosage of MetaFormin and its side
effects.
 Mr D should know the appropriate diet and physical exercises
that should be combined with Metaformin.
Content/Time frame CONTENT TIME
Metaformin is an antidiabetic biguanide with an
antihypeglycemia action that affects transportation
of glucose through cell membranes. The drug
works by increasing the uptake of glucose in the
muscles and other body cells (Hayat et al., 2018).
It also inhibits absorption of intestinal glucose and
hepatic gluconeogenesis which is critical in this
process. Metaformin does not affect the secretion
Three days

TEACHING PLAN 4
of insulin in the body but it has an impact on
circulation of small quantities of insulin in the
blood stream. The medication also works by
lowering lipid levels and through hypotensive
effects which inhibit aggregation of platelets.
 Patient safety is very critical when using any
medication. A patient with a history of severe
kidney diseases or metabolic acidosis should
not use metaformin (Hutchaiah, Boloor &
Thomas, 2019). Additionally, patients with
cardiovascular diseases such as heart failure
as well as liver diseases should not use this
medication since it has contraindication with
other medication and might result to adverse
effects.
 Mr D should follow all the instructions and
the dosage that the doctor prescribed. Mr D
should also carefully read the insert found in
the medication kit and understand the
instructions found in it.
 Metformin should be taken with meals so as

TEACHING PLAN 5
to reduce stomach and bowel effects that may
occur during treatment using this medication
(George et al., 2018).
 The tablet should be swallowed whole with a
glass full of water and should not be crushed
or chewed.
 The oral liquid should be measured with a
marked measuring spoon to ensure that Mr D
takes the right amount of liquid
 The patient should only use one brand of the
medication and should inform the doctor in
case they are using other drugs for other
diseases.
 The dosage of the medication differs from one
patient to another and therefore the patient
should follow the prescription by the doctor
which depends on his blood sugar (Moradi &
Mousavi, 2016).
Topical overview
The teaching section will involve educating the
patient on the meals that they should take in order
to manage the condition. The kind of food the
patient takes is critical in managing blood sugar

TEACHING PLAN 6
for a patient with a diabetes condition. The section
will also involve teaching the patient the necessary
physical exercises which will help the patient to
manage the condition appropriately. Apart from
the use of medication, Mr D needs to adapt a
lifestyle change in order to manage the disease.
Mr D needs to abandon habits such as drinking or
smoking which could make his condition worse.
The teaching section will also involve teaching Mr
D how they can cope with the condition that has
caused them visual impairment as well as
interventions that can help them to recover their
sight.
Individual and family concerns
Individuals using the medication should be
concerned if they have allergies. If Mr D
experiences allergic reactions as a result of using
some medication, it is important that they inform
the doctor so that they can take the necessary
action (Mohammed et al., 2018).
Metaformin should not be used together with
some medication such as Acetriozic acid and

TEACHING PLAN 7
lobenzamic acid. Mr D should therefore inform
the doctor is they are using any other medicine
The drug may cause side effects such as diarrhea,
abdominal discomfort, decreased appetite and
increased anxiety (Killeen et al., 2020).
Mr D can take advantage of community nurses to
help him get therapy and any medical attention
when they are back home. The nurse can also
advice on changes in diet and physical exercises.
The inter-professional role is the role of providing
psychotherapy to the patient to help them cope
with the loss of vision due to the disease.
Teaching
Strategies/Tools/Major
domains of learning
SELECTED STRATEGIES/TOOLS DOMAIN
Lectures is the main teaching strategy that will be
used to offer health education to Mr D. Since Mr
D has a vision impairment (Amin et al., 2019). A
close family member who is his carer will be
taught using visual aids on how to help Mr D take
the medication. Then understand how to take care
of him. The carer should read and understand the
instructions for taking the medication.
Audio learning
because Mr D
has vision
impairment

TEACHING PLAN 8
Additionally, the carer will play a very crucial role
in offering Mr D assistance to help him understand
the physical exercises that he needs to manage his
condition. Demonstration and videos will be used
to educate Mr D carer who will be accompanying
him to the education section so as to help him
understand what he need to do to assist the patient
manage their new condition.
Teaching resources The teaching resources which will be needed include audio
recordings since the patient has visual impairment but he is capable of
hearing and all other senses are working appropriately (Aroda &
Ratner, 2018). The carer will also be provided with the appropriate
reference material which they can consult in case they forget or are
unsure of anything taught to them.
Evaluation The evaluation of the learning will be done by asking Mr D and the
carer questions at the end of the learning sections. This will help to
evaluate what the patient has learned and retained from the lessons
taught. The questions will range from lifestyle changes they need to
adopt, side effects, precautions as well as diet and physical exercises
that are needed when using metaformin drug.
References
Amin, O. S. M., Amin, A. F. A., Karim, S. K., Shwani, S. S., &
Thandoon, R. (2019). Analysis of risk factors for falls in
geriatric patients: a single institutional experience. International

TEACHING PLAN 9
Journal of Advances in Medicine, 6(3), 605.
Aroda, V. R., & Ratner, R. E. (2018). Metformin and Type 2 Diabetes
Prevention. Diabetes Spectrum, 31(4), 336-342.
George, N. E., Sunny, S. M. R. I. T. H. Y., Sam, A. M., Sabu, A. S.,
& Rodrigues, P. A. (2018). Effect of Medication Related
Educational Interventions on Improving Medication Adherence
in Patients With Type 2 Diabetes Mellitus. Asian J of
Pharmaceutical and Clinical Research, 11(1), 167.
Hayat, W., Faisal, M. S., Inayat, A., & Khalil, K. U. R. (2018).
Vitamin b12 deficiency in type II diabetic patients on metformin
therapy; a study conducted in tertiary care hospital of Peshawar.
Journal Of Medical Sciences, 26(2), 151-154.
Hutchaiah, Y., Boloor, A., & Thomas, A. (2019). Cognitive
Impairment in Diabetes-The Causality Association with
Metformin. Available at SSRN 3387524.
Kandula, N. R., Moran, M. R., Tang, J. W., & O’Brien, M. J. (2018).
Preventing diabetes in primary care: providers’ perspectives
about diagnosing and treating prediabetes. Clinical Diabetes,
36(1), 59-66.
Killeen, A. L., Brock, K. M., Dancho, J. F., & Walters, J. L. (2020).
Remote Temperature Monitoring in Patients With Visual
Impairment Due to Diabetes Mellitus: A Proposed Improvement
to Current Standard of Care for Prevention of Diabetic Foot

TEACHING PLAN 10
Ulcers. Journal of diabetes science and technology, 14(1), 37-
45.
Mohammed, H. R., Kadhim, K. A., Alkutubi, H. M., Rahmah, A. M.,
Khalaf, B. H., Hussein, S. A. R., & Fawzi, H. A. (2018).
Correlation between ABO blood groups with insulin resistance
in type II diabetes mellitus patients using Metformin.
International Journal of Research in Pharmaceutical Sciences,
9(3).
Moradi, M., & Mousavi, S. (2016). Drug use evaluation of diabetes
mellitus in nonhospitalized patients. Int J Pharm Pharm Sci,
8(8), 337-41.
Stevens, A., Hamel, J. F., Toure, A., Hadjadj, S., & Boels, D. (2019).
Metformin overdose: a serious iatrogenic complication—
Western France Poison Control Centre data analysis. Basic &
clinical pharmacology & toxicology, 125(5), 466-473.